Product Information
BIKTARVY 30-120-15 MG TABLET is a brand product labeled by Gilead Sciences, Inc., priced at $136.6695 per EA under NDC 61958250501. Its NADAC has been published 110 times since May 22, 2024.
BIKTARVY 30-120-15 MG TABLET
bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarateStrength
30; 120; 15 mg/1; mg/1; mg/1
Manufacturer
Gilead Sciences, Inc.NDC
61958250501
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA210251On Market Since
10/7/2021
Pharmacological Classes
Price Statistics
The NADAC for BIKTARVY 30-120-15 MG TABLET has been published 110 times since May 22, 2024, and over the history we have for it it has risen 6.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $136.6695 per EA |
|---|---|
| All-time high | $136.7316 (Apr 15, 2026) |
| All-time low | $128.6639 (May 22, 2024) |
| 52-week high | $136.7316 |
| 52-week low | $136.4331 |
| Median price | $136.4782 |
| Average price | $134.1569 |
| Largest weekly change | +5.9% (Jan 15, 2025) |
| Weeks tracked | 110 |
| Tracking since | May 22, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BIKTARVY 30-120-15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BIKTARVY 30-120-15 MG TABLET, manufactured by Gilead Sciences, Inc., is $136.6695 per EA (NDC 61958250501), effective Jun 24, 2026.
How has the price of BIKTARVY 30-120-15 MG TABLET changed over time?
Over the history we have for it, the NADAC for BIKTARVY 30-120-15 MG TABLET has risen 6.2%. It has been tracked across 110 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for BIKTARVY 30-120-15 MG TABLET?
Since May 22, 2024, the NADAC for BIKTARVY 30-120-15 MG TABLET has ranged from a low of $128.6639 (May 22, 2024) to a high of $136.7316 (Apr 15, 2026), with a median of $136.4782 per EA.
Are there cheaper alternatives to BIKTARVY 30-120-15 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BIKTARVY 30-120-15 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures BIKTARVY 30-120-15 MG TABLET?
BIKTARVY 30-120-15 MG TABLET (NDC 61958250501) is labeled by Gilead Sciences, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification